Weight-loss drug maker Kailera Therapeutics debuted on Nasdaq on Friday, opening at $26 per share—up 62.5% from its IPO price of $16. Intraday gains held around 57%, with its market value surpassing $2 billion.

DeFi Development Corp (DeFi Dev) has filed a prospectus with the U.S. Securities and Exchange Commission, planning to raise up to 1 billion dollars through the issuance of multiple securities instruments.

According to the latest disclosure filed with the Securities and Exchange Commission, Oncor Electric Delivery Company has received a regulatory directive requiring it to set aside an annual self-insurance reserve of 200 million dollars, specifically designated to cover potential future costs arising from storm events.

Most US stock sector ETFs closed higher, with the aviation ETF rising more than 4.8%

S&P 500 closes at a record high of 7,126 points